+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatitis C Drug"

Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 208 Pages
  • Global
From
Hepatitis C Therapeutics: Competitive Landscape - Product Thumbnail Image

Hepatitis C Therapeutics: Competitive Landscape

  • Report
  • December 2024
  • 84 Pages
  • Global
From
Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035 - Product Thumbnail Image

Liver Fibrosis & NASH/MASH Drugs Market Report 2025-2035

  • Report
  • March 2025
  • 245 Pages
  • Global
From
Liver Disease Treatments Market - Product Thumbnail Image

Liver Disease Treatments Market

  • Report
  • April 2025
  • 164 Pages
  • Global
From
Hepatitis Therapeutics Market Size, Share & Trends Analysis Report By Disease (Hepatitis A, Hepatitis B, Hepatitis C), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Hepatitis Therapeutics Market Size, Share & Trends Analysis Report By Disease (Hepatitis A, Hepatitis B, Hepatitis C), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • August 2024
  • 100 Pages
  • Global
From
Direct-acting Antiviral Drug Market by Product Type, Therapeutic Class, Molecule, Distribution Channel, End User, Indication, Patient Type - Global Forecast to 2030 - Product Thumbnail Image

Direct-acting Antiviral Drug Market by Product Type, Therapeutic Class, Molecule, Distribution Channel, End User, Indication, Patient Type - Global Forecast to 2030

  • Report
  • May 2025
  • 199 Pages
  • Global
From
Hepatitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis Therapeutics - Global Strategic Business Report

  • Report
  • July 2025
  • 298 Pages
  • Global
From
Liver Disease Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Liver Disease Diagnostics - Global Strategic Business Report

  • Report
  • July 2025
  • 380 Pages
  • Global
From
Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • March 2025
  • 181 Pages
  • Global
From
Global Markets for Infectious Disease Treatments - Product Thumbnail Image

Global Markets for Infectious Disease Treatments

  • Report
  • December 2021
  • 245 Pages
  • Global
From
Antiviral Drugs Market Size, Share & Trends Analysis Report By Type (Branded, Generics), By Drug Class, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Antiviral Drugs Market Size, Share & Trends Analysis Report By Type (Branded, Generics), By Drug Class, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Application, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 180 Pages
  • Global
From
Hepatitis C Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Hepatitis C Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 119 Pages
  • Global
From
Hepatitis C Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Hepatitis C Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Hepatitis C Drug Market - Product Thumbnail Image

Hepatitis C Drug Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Hepatitis C - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Hepatitis C - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Hepatitis C Virus (HCV) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Hepatitis C Virus (HCV) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatitis C Virus (HCV) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatitis C Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Hepatitis C Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • July 2024
  • 187 Pages
  • Global
From
Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis C Virus Envelope Protein E2 Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 35 Pages
  • Global
From
Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepatitis C Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 340 Pages
  • Global
From
Loading Indicator

The Hepatitis C Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat the Hepatitis C virus, a contagious virus that can cause liver damage. These drugs are typically administered orally or intravenously and can be used to treat both acute and chronic infections. The drugs are designed to reduce the amount of virus in the body, reduce the risk of liver damage, and improve the quality of life for those infected. The Hepatitis C Drug market is highly competitive, with many companies offering treatments. Some of the major players in the market include Gilead Sciences, AbbVie, Merck, Bristol-Myers Squibb, and Janssen Pharmaceuticals. Other companies, such as Mylan, Cipla, and Natco Pharma, also offer treatments for the virus. Show Less Read more